51cg

Our research , reveals an often-overlooked economic burden faced by women with undiagnosed hypothyroidism.

Using UK nationally representative data, we show that women with undiagnosed hypothyroidism face an 18% gender wage gap. That’s 5% higher than the national average of 13%. This wage penalty doesn’t appear overnight; it begins to impact women’s earnings up to five years before they receive a diagnosis.

These findings align with insights from our Thyroid Patient Survey [link to survey page], which shows that many thyroid patients endure symptoms for an average of five years before receiving a confirmed diagnosis.

However, a diagnosis can be a turning point. Our research shows that once women are diagnosed, they typically see improvements in their wage recovery and employment prospects.

By understanding the hidden economic costs of thyroid dysfunctions, we can advocate for better healthcare policies, workplace adjustments, and employer support to ensure that people with thyroid conditions receive the care and understanding they need to thrive in their professional lives.

Our provides some very important insights into the often-overlooked realities of living with thyroid dysfunctions. It reveals the difficult path many patients face from symptom onset to diagnosis, particularly for those with hypothyroidism—the most common thyroid condition.

The data shows that it takes an average of 4.5 years for patients to receive a confirmed diagnosis of a thyroid condition, with the wait being longer for those suffering from hypothyroidism. This lengthy process typically involves multiple doctor visits and worsening symptoms before patients finally get answers.

Even after starting treatment, many patients continue to struggle. Persistent issues such as fatigue, cognitive difficulties, muscle weakness, weight fluctuations, and mental health challenges remain all too common. Alarmingly, 20% of respondents reported seeing no improvement in their symptoms despite receiving treatment, and only a small fraction expressed satisfaction with their outcomes.

Navigating the workplace with a chronic health condition like thyroid dysfunction can be challenging. However, our research uncovers the crucial role that thyroid patients’ voice in the workplace can play in improving the work experience.

Our findings reveal that employees dissatisfied with their thyroid treatment are more likely to disclose their condition to their employer. The response from employers plays a critical role in shaping the impact of thyroid conditions on work engagement. When employers react with understanding and sympathy, the adverse effects of thyroid conditions on work engagement are significantly reduced.

Our research highlights a clear message: open communication and support in the workplace are key. When employees feel safe to share their health challenges and receive a positive response, they are more likely to thrive professionally. Supportive employers can directly improve labour market outcomes for employees with thyroid conditions, improving labour market outcomes, such as wages, promotion prospects, job mobility, and working hours.

Employers have the power to make a difference in the lives of their employees with chronic health conditions. By adopting compassionate policies, promoting open conversations, and offering reasonable adjustments, they can help create a healthier, more inclusive workplace for all.

Thyroid Patients' Voice in Healthcare

Good healthcare starts with good communication, but being heard is about more than communication alone. Our survey of people living with thyroid disease highlighted significant challenges in the dialogue between thyroid patients and healthcare professionals. One-third of respondents shared that they didn’t feel heard during consultations. This issue is particularly pronounced among hypothyroidism patients, who reported lower levels of involvement, empowerment and being heard compared to individuals with other thyroid conditions.

Our latest research, published in , takes this work further by examining how the specialty and gender of the diagnosing doctor shape women's experiences of patient voice. Women diagnosed by specialist consultants reported higher levels of patient voice than those diagnosed by GPs. They were more likely to feel involved in decisions about their treatment, empowered to contribute to their care, and heard by healthcare professionals. Among consultants, female consultants generated stronger patient voice than male consultants. No gender differences were found among GPs.

These findings point to the importance of the clinical setting in determining the extent to which patients feel heard and empowered. In primary care, healthcare systems may not provide clinicians with the time, specialised knowledge and diagnostic frameworks needed to interpret often complex and overlapping symptoms, making it harder to recognise and understand patients’ experiences, regardless of the GP’s gender.  Once the condition is being considered within a more specialised clinical setting, the interpersonal dynamics of the doctor-patient relationship may become particularly important.

This matters because our earlier research shows that patient voice is associated with wider outcomes. When thyroid patients feel involved, empowered and heard, they report greater satisfaction with their treatment, better physical health and overall wellbeing, improved family and social relationships and better labour market outcomes, including higher wages.

Our research highlights the importance of putting patient voice at the centre of thyroid care. Improving care requires more than encouraging individual healthcare professionals to communicate better. It also means strengthening knowledge and referral pathways, recognising the varied presentation of thyroid disease, and creating opportunities for patients to play a meaningful role in decisions about their care.